ロード中...
Pembrolizumab-Induced Delayed-Onset Hepatitis
Hepatitis is one of the serious immune-related adverse events (irAEs). However, delayed-onset hepatitis induced by immune-checkpoint inhibitors (ICIs) is rare, and the histopathological features remain to be clarified. A 65-year-old woman with advanced lung adenocarcinoma in the right upper lobe (cT...
保存先:
| 出版年: | Case Rep Gastroenterol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger AG
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7670324/ https://ncbi.nlm.nih.gov/pubmed/33250701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000509953 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|